1. Home
  2. Live Updates
  3. Kremer hovinga

Live Breaking News & Updates on Kremer hovinga

Stay informed with the latest breaking news from Kremer hovinga on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Kremer hovinga and stay connected to the pulse of your community

Takeda Announces Approval of ADZYNMA® Intravenous Injection 1500 (apadamtase alfa /cinaxadamtase alfa) in Japan for Patients with Congenital Thrombotic Thrombocytopenic Purpura (cTTP)

cTTP is an Ultra-rare Blood Clotting Disorder Associated with Life-Threatening Acute Events and Debilitating Chronic Symptoms



ADZYNMA is the First and Only Recombinant ADAMTS13 Enzyme...

United-states , Japan , Japanese , Yasushi-kajii , Thromb-haemost , Kremer-hovinga , Van-dorland , European-medicines-agency , Japan-ministry-of-health , Takeda-pharmaceutical-company-limited , Exchange-commission , Drug-administration

Pivotal Phase 3 Data Presented at ISTH 2023 Congress Spotlight TAK755 Prophylaxis for Patients with Congenital Thrombotic Thrombocytopenic Purpura cTTP

Takeda TSE 4502NYSETAK today presented favorable interim results from a global pivotal Phase 3 randomized controlled openlabel crossover trial evaluating the safety and efficacy of TAK755 recombinant ADAMTS13 replacement therapy for the prophylactic treatment of congenital thrombotic thrombocytopenic purpura cTTP and pharmacokinetics PK characteristics of TAK755 as well as longterm data on TAK755 prophylaxis from a Phase 3b continuation study.

London , City-of , United-kingdom , Osaka , Japan , United-states , Japanese , J-thromb-haemost , Kremer-hovinga , Daniel-curran , Jun-saito , Van-dorland

Pivotal Phase 3 Data Presented at ISTH 2023 Congress Spotlight TAK-755 Prophylaxis for Patients with Congenital Thrombotic Thrombocytopenic Purpura (cTTP)

OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jun 25, 2023--

London , City-of , United-kingdom , United-states , Massachusetts , Osaka , Japan , Japanese , Jun-saito , Megan-ostrower , Marie-scully , Daniel-curran

Pivotal Phase 3 Data Presented at ISTH 2023 Congress Spotlight TAK-755 Prophylaxis for Patients with Congenital Thrombotic Thrombocytopenic Purpura (cTTP)

OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jun 25, 2023--

London , City-of , United-kingdom , Japan , Massachusetts , United-states , Osaka , Japanese , Van-dorland , Daniel-curran , Megan-ostrower , Jun-saito

Frequency of Thrombocytopenia and Platelet Factor 4/Heparin Antibodies in Patients With Cerebral Venous Sinus Thrombosis Prior to the COVID-19 Pandemic | Coagulation Disorders | JAMA

Frequency of Thrombocytopenia and Platelet Factor 4/Heparin Antibodies in Patients With Cerebral Venous Sinus Thrombosis Prior to the COVID-19 Pandemic | Coagulation Disorders | JAMA
jamanetwork.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jamanetwork.com Daily Mail and Mail on Sunday newspapers.

Switzerland , Hamadan , Iran , United-states , Bern , Canada , Amsterdam , Noord-holland , Netherlands , Uusimaa , Uusimaa-region , Finland